CLINICAL FOCUS ›› 2006, Vol. 21 ›› Issue (10): 690-692.
Previous Articles Next Articles
Clinical observation of therapeutic efficacy of elastase on nonalcoholic fatty liver disease with hyperlipidemia
LI Jun-feng;YANG Dong-hua
-
Online:2006-05-20Published:2006-05-20
| [1] | You Yilan, Chen Lingyan, Miao Keyan, Ni Luohang, Zhang Yan, Xiao Jianping. Clinical predictive value of urine organic acid metabolites in intrahepatic cholestasis of pregnancy [J]. Clinical Focus, 2025, 40(6): 519-526. |
| [2] | Kong Li, Zhao Suxian, Zhang Ying, Jin Meng, Wang Shanshan, Ren Weiguang, Zhang Yuguo, Kong Lingbo, Han Fang, Ji Lei. Expression levels of TIPE2 and FOXP3 in patients with hepatocellular carcinoma and cirrhosis and their clinical significance [J]. Clinical Focus, 2025, 40(5): 412-416. |
| [3] | Zhao Xueting, Bai Jiawen, Sun Jun. Analysis of risk factors for liver fibrosis in metabolic dysfunction-associated fatty liver disease and construction of a nomogram [J]. Clinical Focus, 2025, 40(5): 417-422. |
| [4] | Su Rui, Wang Cunkai, Wang Dingxin, Cai Conghui, Zhang Jian, Hou Hongtao, Bai Yun. Efficacy and safety of anticoagulant therapy in patients with cirrhosis: A meta-analysis [J]. Clinical Focus, 2025, 40(4): 293-303. |
| [5] | Lin Tao, Du Taoming, Li Ya, Feng Yuling, Song Huizhen, Yu Qin. Value of T2WI signal intensity and gadobemeglumine enhanced MRI hepatobiliary phase parameters in evaluating liver function of cirrhosis patients [J]. Clinical Focus, 2025, 40(3): 251-256. |
| [6] | Tong Mingxia, Chen Ke, Xiang Xiaocong, Zhou Lifeng. Analysis of lean metabolic-associated fatty liver disease among young and middle-aged people and its risk factors [J]. Clinical Focus, 2025, 40(2): 128-132. |
| [7] | Qian Chenying, Yan Wenjun, Huang Yan, Zhao Zhi. Analysis of risk factors for multidrug-resistant bacterial infection in patients with decompensated cirrhosis [J]. Clinical Focus, 2025, 40(2): 143-146. |
| [8] | Sun Ya, Yang Shuang. Value of ultrasound-guided attenuation parameter in the quantitative assessment of hepatic steatosis [J]. Clinical Focus, 2025, 40(2): 158-161. |
| [9] | Gou Caixia, Zhang Jie, Baoyixiamu·Ababaikeli , Wang Yiming, Yao Lei, Zheng Rongjiong, Pan Jinliang, Lu Xiaobo. Analysis of influencing factors of sleep quality and metabolically associated fatty liver disease in the physical examination population [J]. Clinical Focus, 2025, 40(1): 33-38. |
| [10] | Zhang Shasha, Zhao Yingchun, Zhou Hongxia. Effect of low-level viremia on the incidence of hepatocellular carcinomas in patients with hepatitis B cirrhosis treated with entecavir [J]. Clinical Focus, 2024, 39(11): 980-983. |
| [11] | . [J]. Clinical Focus, 2024, 39(10): 935-939. |
| [12] | Qin Qiaoling, Mo Ranghui, Chen Xinyi. Efficacy and safety of the direct-acting anti-HCV therapy based on efavirenz-containing regimen on HIV/HCV co-infected patients [J]. Clinical Focus, 2024, 39(10): 921-924. |
| [13] | Wu Qiupin, Yan Shiwei, He Xiaoyin, Li Yun, LU Liju, Wu Yi. Analysis of hepatitis associated aplastic anemia in children [J]. Clinical Focus, 2024, 39(7): 640-643. |
| [14] | . [J]. Clinical Focus, 2024, 39(7): 658-663. |
| [15] | . [J]. Clinical Focus, 2024, 39(2): 177-182. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||